
bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2025, Номер unknown
Опубликована: Апрель 20, 2025
ABSTRACT Objective We have established a comprehensive sample handling protocol designed for the multiscale assessment of epileptogenic tissue. This aims to identify novel therapeutic targets and enhance diagnosis stratification patients with drug-resistant epilepsy, thereby optimizing their treatment anti-seizure medications surgical interventions. Methods Patients focal recommended treatment, are recruited after detailed multidisciplinary preoperative evaluation at Epilepsy Center Kuopio University Hospital in Finland. A day before resective surgery, undergo magnetic resonance imaging (MRI) including advanced methodologies. During each piece resected tissue is placed under oxygenation on ice-cold artificial cerebral spinal fluid-solution. The pieces then immediately transported laboratory, assessed by neuropathologist, sliced both clinical research. Two adjacent slices provided research sent Eastern Results developed provides opportunity characterization from same patient using emerging imaging, electrophysiology, molecular biology technologies. optimized conditions preserving alive electrophysiological measurements simultaneously making possible ex vivo studies multi-omics acquisition, electron microscopy, histology, MRI. Our enables mapping functional readouts structural alterations human goal integrate multimodal data co-register tissues within whole brain’s MRI space. approach localization zones refine identifying abnormalities global connectivity patterns. Significance successfully systematic collection analysis data. elucidate structural, functional, characteristics that render epileptogenic, enhancing subsequent care epilepsy. Key points Introducing assess epileptogenicity levels. integrating technology properties obtain patient-specific Correlation predict pathology
Язык: Английский